VEDS Scientific Meeting Day 2022

Join Veristat and ACER Therapeutics at the VEDS Scientific Meeting Day  2022

ACER Therapeutics Decentralized Study Design: A Phase 3 Clinical Study in Patients with COL3A1-Positive Vascular Ehlers-Danlos Syndrome to Determine Whether Celiprolol Delays the Onset of VEDS-related Clinical Events abstract has been accepted to the poster session.

The one-day in-person meeting will be held on Monday, August 29, 2022, from 8:00am – 5:00 pm in Paris, France, as part of The Marfan Foundation’s Science in Paris meeting. Follow the conference link (below) to learn more.

Conference Details

Website: https://thevedsmovement.org/